# LumenAI Launch Readiness Checklist
Version 1.0 | Commercial — CONFIDENTIAL

**Legend**: Complete | In Progress | Not Started | N/A for MVP

---

## Product

| Item | Status | Notes |
|------|--------|-------|
| All P0–P13 features verified passing (1,184 tests) | Complete | `pytest tests/ -q` passes |
| Frontend builds clean | Complete | `npm run build` no errors |
| Mobile-responsive UI verified | In Progress | Responsive breakpoints implemented; mobile QA pending |
| Dark mode / accessibility (WCAG 2.1 AA) | In Progress | Base styles complete; full audit pending |

---

## Security

| Item | Status | Notes |
|------|--------|-------|
| P0/P1 security hardening complete | Complete | Rate limiting, security headers, CORS, auth |
| Rate limiting applied to inference endpoints | Complete | slowapi; /api/cv/inspect limited |
| SECRET_KEY production guard active | Complete | App exits on startup with default key in production |
| Dev-token blocked in production | Complete | require_enterprise_auth enforces JWT-only |
| External pentest scheduled | In Progress | Target Q2 2026 |
| Secrets in Vault / Secrets Manager (not hardcoded) | In Progress | Pattern established; Vault migration pending |
| CORS restricted to production domains | Complete | settings.CORS_ORIGINS configurable |
| gitleaks scan clean | In Progress | Run in CI pipeline; clean on current branch |

---

## Clinical Validation

| Item | Status | Notes |
|------|--------|-------|
| P12 validation module operational | Complete | /api/validation/* endpoints live |
| Mock performance data published | Complete | Simulated kappa, sensitivity, specificity |
| Live reader study scheduled | In Progress | Target Q3 2026 with clinical partner |
| Kappa monitor endpoint live | Complete | /api/validation/kappa-monitor |

---

## Regulatory

| Item | Status | Notes |
|------|--------|-------|
| P13 regulatory documentation complete | Complete | docs/regulatory/ |
| Intended use finalized | Complete | Decision support; not diagnostic |
| SaMD pathway assessment complete | Complete | P13 samd-classification.md |
| Regulatory counsel engaged | In Progress | External counsel retained |
| FDA Q-submission prepared | Not Started | Target Q4 2026 |

---

## Infrastructure

| Item | Status | Notes |
|------|--------|-------|
| K8s manifests deployed to staging | Complete | deployment.yaml, hpa.yaml, pdb.yaml |
| HPA configured (min 2, max 10) | Complete | P11 hpa.yaml |
| PDB configured (minAvailable: 1) | Complete | P11 pdb.yaml |
| /health endpoint live | Complete | 200 OK with version |
| /ready endpoint live | Complete | 503 if DB unreachable |
| Structured JSON logging enabled | Complete | JSONFormatter at startup |
| Correlation ID middleware active | Complete | X-Correlation-ID on every response |
| PostgreSQL configured for production | In Progress | SQLite for dev; Postgres via DATABASE_URL |

---

## Support

| Item | Status | Notes |
|------|--------|-------|
| Support email configured (support@lumenai.com) | In Progress | Mailbox provisioning pending |
| Incident response runbook complete | Complete | deployment-readiness-validation.md |
| SEV1 < 1-hour response SLA documented | Complete | P11 reliability.md + this document |
| Customer communication templates ready | Complete | Maintenance, incident, postmortem templates |
| CSM assigned for first 3 customers | Not Started | Hire/assign before first pilot go-live |

---

## Sales

| Item | Status | Notes |
|------|--------|-------|
| Sales playbook published | Complete | docs/sales/sales-playbook.md |
| Demo environment provisioned | In Progress | Staging env available; demo data seeding needed |
| Pilot framework defined | Complete | docs/customer/pilot-program-framework.md |
| ROI model validated with pilot data | In Progress | Model complete; pilot data pending first customer |
| Pricing approved by leadership | In Progress | Pricing strategy documented; final approval pending |

---

## Customer Success

| Item | Status | Notes |
|------|--------|-------|
| Onboarding playbook complete | Complete | docs/customer/customer-onboarding-playbook.md |
| Go-live checklist operationalized | Complete | Embedded in onboarding playbook |
| QBR template ready | Complete | docs/customer/customer-success-playbook.md |
| CSM tooling (CRM, health score) configured | Not Started | Salesforce setup needed |
| Training materials created | In Progress | Content outlined; slide deck production pending |

---

## Commercial

| Item | Status | Notes |
|------|--------|-------|
| Product packaging finalized | Complete | docs/commercial/product-packaging.md |
| Pricing approved by leadership | In Progress | Draft complete; leadership review pending |
| HIPAA BAA template reviewed by counsel | In Progress | Template drafted; counsel review pending |
| MSA / order form template reviewed by counsel | In Progress | Template drafted; counsel review pending |
| First pilot customer identified | In Progress | Active sales conversations underway |

---

## Executive Dashboards (P14)

| Item | Status | Notes |
|------|--------|-------|
| /api/executive/dashboard/{role} endpoint live | Complete | 7 roles: spd_director, infection_prevention, quality_leadership, coo, cno, cfo, market_director |
| /api/executive/summary endpoint live | Complete | Cross-role headline KPI summary |
| All endpoints require auth | Complete | require_enterprise_auth on all routes |
| Tests passing for executive endpoints | Complete | test_p14_commercial.py — 25 tests |

---

## Launch Go/No-Go Summary

| Domain | Go/No-Go | Blocker (if No-Go) |
|--------|----------|-------------------|
| Product | Go | None |
| Security | Conditional Go | External pentest before GA |
| Clinical Validation | Conditional Go | Live reader study before GA claims |
| Regulatory | Conditional Go | Counsel review before GA |
| Infrastructure | Conditional Go | PostgreSQL prod config before GA |
| Sales & CS | Go for Pilot | CSM hire before pilot customer go-live |
| Commercial | Go for Pilot | Pricing approval and legal review before GA |

**Recommendation**: Proceed with controlled pilot launch (3–5 design partners).
Resolve conditional items before General Availability (GA) announcement.
Target GA: Q3 2026 aligned with live reader study completion.
